Investing
606 Articles
These are some of the key analyst downgrades and negative analyst calls we have seen early this Monday morning with…
Carl Icahn has evolved over the years, first rising to fame a "corporate raider", followed by an ill-fated journey into…
Elan Corporation (ELN) Problems with one of the company’s major drugs. Falls to $9.55 from 52-week high of $37.45. Gatehouse…
This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We…
Genentech Inc. (NYSE: DNA) is set to report earnings after the close of trading today. The largest biotech in the…
There was interesting event in a 13D filing today right after the close, and that will be worth some news…
Carl Icahn is a billionaire financier, activist, and investor. Most think of Icahn as an activist investor that wants to…
Genentech, Inc. (NYSE:DNA) and Biogen Idec, Inc. (Nasdaq:BIIB) came out this morning with some disappointing news. The biotech giants have…
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on…
Thursday after the close, we’ll get to see earnings out of Genentech (NASDAQ: DNA). The estimates from First Call are…
Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look…
Billionaire activist investor and financier Carl Icahn has released the total holdings in an SEC filing for the period end…
On Wednesday, we’ll get to see earnings out of Biogen Idec Inc. (NASDAQ: BIIB). The estimates from First Call for…
Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis. This…
Alliance Data Systems (ADS) was informed by Blackstone that conditions likely won’t be satisfied to complete the merger; stock trading…
Our top personal finance-related articles today. Your wallet will thank you later.